The following publications are possibly variants of this publication:
- Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro StudySouvik Banerjee, Shalini Yadav, Sourav Banerjee, Sayo O. Fakayode, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Foyez Mahmud, Ryan Whatcott, Joshua Thammathong, Bernd Meibohm, Duane D. Miller, Colleen Jonsson, Kshatresh Dutta Dubey. jcisd, 61(11):5469-5483, 2021. [doi]
- A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigationAhmed Rakib, Zulkar Nain, Saad Ahmed Sami, Shafi Mahmud, Ashiqul Islam, Shahriar Ahmed, Adnan Bin Faisul Siddiqui, S. M. Omar Faruque Babu, Payar Hossain, Asif Shahriar, Firzan Nainu, Talha Bin Emran, Jesus Simal-Gandara. bib, 22(2):1476-1498, 2021. [doi]